Connect your AI

Absci Corporation ABSI Debt Repayments

Debt Repayments at other companies

Recursion Pharmaceuticals, Inc.RXRX

$2.21M+7.9%

BridgeBio PharmaBBIO

$0-100%

AbbottABT

$1.42B+41.5%

Other financials

Income statement

Revenue$215.0K-81.8%

Operating income-$30.8M-11.2%

Net income-$29.6M-12.3%

EPS (diluted)-$0.19+9.5%

Balance sheet

Cash & equivalents$9.7M-84.9%

Total debt$4.0M-37.2%

Total equity$172.0M-13.5%

Total assets$195.6M-15.9%

Cash flow

Operating cash flow-$26.3M-20.5%

CapEx$30.0K+20.0%

Free cash flow-$26.3M-20.5%

Valuation

Market cap$1.57B+43.6%

Enterprise value$1.57B+73.1%

P/S855.5×+628×

Profitability

Operating margin-6,723%-14,525pp

Net margin-6,450.8%-13,699pp

FCF margin-5,365.2%-9,300pp

Returns & leverage

Return on equity-63.9%+28.0pp

Debt / equity0×0.0×

Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Absci Corporation's debt repayments?: Absci Corporation (ABSI) reported debt repayments of $460K in Q1 2026.
How has Absci Corporation's debt repayments changed year-over-year?: Absci Corporation's debt repayments decreased by 39.6% year-over-year, from $762K to $460K.
What is the long-term trend for Absci Corporation's debt repayments?: Over 4 years (2021 to 2025), Absci Corporation's debt repayments has grown at a 18.1% compound annual growth rate (CAGR), from $1.6M to $3.12M.
What does debt repayments mean?: Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.